MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a

Publication date: Available online 22 January 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Maria P. Sormani, Mark S. Freedman, Julie Aldridge, Kurt Marhardt, Ludwig Kappos, Nicola De Stefano
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research